DHEA and Adrenal Androgens
The Precursor Pool: What DHEA and DHEA-S Actually Do (and Don't) in Men
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Sold as a dietary supplement in the US (not FDA-approved as a drug)
- WADA
- Prohibited (S1 Anabolic Agent / prohormone)
Reference only. Not medical advice.
What can go wrong
DHEA can cause androgenic effects (acne, oily skin, hair pattern changes), may affect lipid profiles, and as an unregulated supplement carries purity and dosing-consistency concerns. It is prohibited in competitive sport. Because it can be peripherally converted to estrogen and androgens, effects are unpredictable. It is not a substitute for evaluating genuine hypogonadism.
This is something to take to a clinician. The Atlas can tell you what is known about dhea and adrenal androgens in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) are adrenal-cortex steroids that serve as a precursor reservoir, peripherally convertible into testosterone and estradiol in target tissues. DHEA-S is the most abundant circulating steroid in the human body, and its levels decline steadily with age (adrenopause), which fueled decades of anti-aging marketing. The honest evidence: in men with intact adrenal function, oral DHEA supplementation produces small and inconsistent effects on testosterone, body composition, libido, and well-being, and does NOT reliably treat male hypogonadism. Its clearest legitimate use is in primary adrenal insufficiency, where the adrenal androgen pool is genuinely depleted, and even there benefits are modest and debated. In the US, DHEA is sold as an unregulated supplement, and it is a prohibited substance in sport.
The most abundant steroid in the bloodstream, and one of the most over-promised supplements. A precursor, not a magic bullet.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
DHEA is an intermediate in steroidogenesis: it can be converted in peripheral tissues to androstenedione and then to testosterone and estradiol via intracrine pathways (the concept of 'intracrinology' developed by Labrie). This means DHEA's effects are tissue-local and depend on each tissue's enzymatic machinery, which varies between individuals and by sex. In men with already-adequate adrenal and gonadal output, adding DHEA tends to be buffered by feedback and limited conversion, which is why supraphysiologic supplementation often fails to meaningfully raise testosterone or produce consistent clinical benefit.
Why a steep age-related decline did NOT translate into a useful therapy
DHEA-S falls dramatically with age, and observational studies linked low levels to frailty and mortality, an attractive anti-aging story. But randomized trials largely failed to deliver. The most cited is Nair et al. (NEJM 2006): two years of DHEA (and separately low-dose testosterone) in elderly men and women produced no meaningful improvement in body composition, physical performance, insulin sensitivity, or quality of life. This is the cautionary pattern of replacing a declining biomarker without proof that the decline is causal or that replacement helps. DHEA remains a precursor with real biochemistry but weak clinical payoff for healthy aging men.
What people get wrong
Often saidDHEA is a 'natural' way to raise testosterone
ActuallyIn men with normal adrenal and gonadal function, DHEA does not reliably raise testosterone or improve outcomes; the best RCT (Nair 2006) was negative.
Often saidBecause DHEA declines with age, replacing it reverses aging
ActuallyReplacing a declining biomarker is not the same as treating a disease. Trials have not shown that DHEA supplementation reverses age-related decline in healthy men.
Often saidDHEA is just a harmless supplement
ActuallyDHEA is an androgen precursor, is WADA-prohibited in sport, can cause androgenic side effects (acne, hair changes), and is unregulated for purity in the US supplement market.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- Are there any specific male subgroups (e.g., true adrenal insufficiency) with a reproducible DHEA benefit?
- Does individual variation in intracrine enzyme activity explain inconsistent responses?
- What are the long-term safety implications of chronic supraphysiologic DHEA use?
At a glance
- Source
- Adrenal cortex (zona reticularis); also gonads
- Most abundant steroid
- DHEA-S, by circulating concentration
- Age pattern
- Peaks in 20s, declines steadily (adrenopause)
- US status
- Dietary supplement; WADA-prohibited in sport
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about DHEA and Adrenal Androgens. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Nair et al., NEJM2006
Two-year DHEA replacement in elderly men/women showed no significant benefit in body composition, physical function, or quality of life
DHEA in adrenal insufficiency trials2000s
Modest, inconsistent improvements in well-being/libido in women with adrenal insufficiency; weaker and contested evidence in men
Observational adrenopause cohorts1990s-2000s
Low DHEA-S associated with aging/frailty, but association did not prove that supplementation reverses outcomes